Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia

NCT00281931 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Prolymphocytic Leukemia

Interventions

BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: fludarabine phosphate

Sponsor

German CLL Study Group